Proactive Investors - Run By Investors For Investors

Crescita Therapeutics leverages its unique drug delivery systems and a strong pipeline for growth

Crescita Therapeutics Inc. (TSX:CTX) executive chairman of the Board Dan Chicoine talks to Proactive about the rapid growth of its prescription dermatology lines and how it is leveraging its unique drug delivery systems to support growth of its product lines.

He also discussed how the company deals with intense competition in the skincare industry.

 
View full CTX profile View Profile

Crescita Therapeutics Inc Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use